About the company
Tabuk Pharmaceutical Manufacturing Company (“Tabuk”) develops, manufactures, markets and distributes branded generic pharmaceuticals and under-licensed products globally. Established in 1994 in Saudi Arabia, Tabuk Pharmaceuticals’ fast growth has allowed it to become a global company, with a strong focus on the Middle East and North Africa region. Today, the company is present in over 20 markets and employs over 1,500 employees. Tabuk Pharmaceuticals operates in multiple therapeutic areas including CNS, cardiovascular, anti-infectives, respiratory, and muscular skeletal system
Tabuk Pharmaceuticals’ distinctive marketing capabilities, state-of-the-art manufacturing facilities, broad product portfolio, deep understanding of pharmaceutical regulations, and strong partnerships and affiliations, helped create a leading pharmaceutical player in the MENA region
Tabuk Pharmaceuticals’ aim is to consistently exceed the demands of our patients by providing them with the best quality drugs at affordable prices. It is a fully owned subsidiary of Astra Industrial Group, a publicly traded company on the Saudi stock exchange
One of the largest Saudi Pharmaceutical companies with strong MENA presence
25 years of proven experience in pharmaceuticals and healthcare
Over 250 registered products
Key under licensed partner
Injectable leader in the Middle East
